TNGX - Tango Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$34.83
DETAILS
HIGH:
$55.00
LOW:
$24.00
MEDIAN:
$31.50
CONSENSUS:
$34.83
UPSIDE:
72.08%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 96.3% |
| EBIT Margin | -178.4% |
| EBITDA Margin | -174.7% |
| Operating Margin | -178.4% |
| Pretax Margin | -162.8% |
| Cont. Ops Margin | -162.9% |
| Net Margin | -162.9% |
| Bottom Line Margin | -162.9% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 16.32 |
| Quick Ratio | 16.32 |
| Solvency Ratio | -1.891 |
| Cash Ratio | 5.18 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-10.13
Peers avg: 16.1
|
| PEG Ratio | 0.38 |
| Forward PEG | 0.38 |
| Price/Book | 2.97 |
| Price/Sales | 16.50 |
| Price/FCF | -7.36 |
| Price/Op Cash Flow | -7.41 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0842 |
| Debt/Equity | 0.0970 |
| Debt/Capital | 0.0884 |
| Long-Term Debt/Capital | 0.0818 |
| Financial Leverage | 1.15 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.22 |
| Operating Cash Flow Ratio | -6.406 |
| Operating Cash Flow/Sales | -222.6% |
| Free Cash Flow/Operating Cash Flow | 100.8% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -39.81 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -50.73 |
| Operating Cash Flow Coverage | -4.14 |
| Capital Expenditure Coverage | -132.52 |
| Dividend + Capital Expenditure Coverage | -132.52 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.54 |
| EPS | -0.875 |
| Debt/Share | 0.2890 |
| Cash/Share | 2.95 |
| Book Value/Share | 2.98 |
| Tangible BV/Share | 2.98 |
| Equity/Share | 2.98 |
| Operating Cash Flow/Share | -1.196 |
| Capital Expenditure/Share | 0.009 |
| FCF/Share | -1.205 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.913 |
| Price/Fair Value | 2.97 |
| Debt/Market Cap | 0.0326 |
| Effective Tax Rate | -0.0% |
| Enterprise Value Multiple | -8.72 |